Biogen MA Inc.

URI: https://gptkb.org/entity/Biogen_MA_Inc.

GPTKB entity

Statements (61)

Predicate	Object
gptkbp:instance_of	gptkb:biotechnology
gptkbp:acquisition	gptkb:Zymeworks Nightstar Therapeutics
gptkbp:ceo	gptkb:Michel_Vounatsos
gptkbp:clinical_trial	gptkb:amyotrophic_lateral_sclerosis gptkb:muscular_dystrophy gptkb:neurodegenerative_diseases gptkb:multiple_sclerosis
gptkbp:employees	7000
gptkbp:founded	gptkb:1978
gptkbp:founder	gptkb:M._Keith_Yamamoto
gptkbp:headcount	7000 (2021)
gptkbp:headquarters	gptkb:Cambridge,_Massachusetts
https://www.w3.org/2000/01/rdf-schema#label	Biogen MA Inc.
gptkbp:industry	gptkb:biotechnology
gptkbp:location	gptkb:Europe gptkb:Asia gptkb:United_States
gptkbp:market_cap	$40 billion (2021)
gptkbp:net_income	$3.56 billion (2020)
gptkbp:partnership	gptkb:Genentech gptkb:Samsung_Bioepis gptkb:Takeda_Pharmaceutical_Company gptkb:Acorda_Therapeutics gptkb:Alnylam_Pharmaceuticals gptkb:Merck_KGa_A gptkb:Astra_Zeneca gptkb:Astra_Zeneca_PLC gptkb:Sanofi gptkb:Boehringer_Ingelheim gptkb:Bristol-Myers_Squibb gptkb:Neurocrine_Biosciences gptkb:Pfizer gptkb:Regeneron_Pharmaceuticals gptkb:Horizon_Therapeutics gptkb:Merck_&_Co. gptkb:Roche gptkb:Bristol-Myers_Squibb_Company gptkb:Amgen gptkb:Gilead_Sciences gptkb:Eisai gptkb:Samsung_Biologics gptkb:Vertex_Pharmaceuticals gptkb:Ionis_Pharmaceuticals gptkb:Abb_Vie gptkb:Cure_Vac_AG gptkb:Sarepta_Therapeutics gptkb:Cure_Vac gptkb:Novartis gptkb:Sage_Therapeutics
gptkbp:products	gptkb:Tecfidera gptkb:Spinraza gptkb:Avonex gptkb:Aducanumab
gptkbp:research_focus	neurological diseases
gptkbp:revenue	$13.45 billion (2020)
gptkbp:stock_symbol	gptkb:BIIB
gptkbp:subsidiary	gptkb:Ionis_Pharmaceuticals
gptkbp:website	www.biogen.com
gptkbp:bfsParent	gptkb:Biogen
gptkbp:bfsLayer	4